 Connection
Colin Mant to Hemolysis
This is a "connection" page, showing publications Colin Mant has written about Hemolysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.243 |
|
|
|
-
Mant CT, Jiang Z, Gera L, Davis T, Nelson KL, Bevers S, Hodges RS. De Novo Designed Amphipathic a-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii. J Med Chem. 2019 04 11; 62(7):3354-3366.
Score: 0.153
-
Jiang Z, Mant CT, Vasil M, Hodges RS. Role of positively charged residues on the polar and non-polar faces of amphipathic a-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens. Chem Biol Drug Des. 2018 01; 91(1):75-92.
Score: 0.034
-
Huang Y, Pan L, Zhao L, Mant CT, Hodges RS, Chen Y. Structure-guided RP-HPLC chromatography of diastereomeric a-helical peptide analogs substituted with single amino acid stereoisomers. Biomed Chromatogr. 2014 Apr; 28(4):511-7.
Score: 0.026
-
Chen Y, Vasil AI, Rehaume L, Mant CT, Burns JL, Vasil ML, Hancock RE, Hodges RS. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem Biol Drug Des. 2006 Feb; 67(2):162-73.
Score: 0.015
-
Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem. 2005 Apr 01; 280(13):12316-29.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|